Hikma Pharmaceutical | HIK - Debt

Stock Price
1,285.50
Daily Change
-22.50 -1.72%
Monthly
7.93%
Yearly
-30.17%
Q2 Forecast
1,279.62

Hikma Pharmaceutical reported $1.56B in Debt for its fiscal semester ending in June of 2025.





Debt Change Date
Almirall EUR 342.86M 61.94M Dec/2025
argenx SE USD 43.15M 4.1M Jun/2025
AstraZeneca USD 32.63B 207M Sep/2025
Autolus Therapeutics Ltd USD 253.44M 8.84M Mar/2025
Bayer EUR 39.39B 1.31B Mar/2025
Fresenius EUR 12.85B 778M Jun/2025
Galapagos EUR 7.5M 3.36M Sep/2025
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 12.1B 2.7B Sep/2025
Orion EUR 305.4M 15.8M Dec/2025
Recordati EUR 2.5B 33.23M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024